2BBBullish & Bearish
Merck & Company, Inc. Common Stock (new) (MRK) trades on NYSE. It operates in the Health Care sector, Drug Manufacturers - General industry. Its current 2BB score is 22 out of 100.
Merck & Co., Inc. is an American multinational pharmaceutical company headquartered in Rahway, New Jersey. The company does business as Merck Sharp & Dohme or MSD outside the United States and Canada. The company is ranked fifth on the list of largest biomedical companies by revenue. The company's revenues are primarily from cancer treatments, vaccines, and animal health products.
Merck & Company, Inc. Common Stock (new)’s current 2BB score is 22 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 12 | Very Low |
| Momentum | 50 | Stable |
| Financial strength | 45 | Normal |
| Quality | 100 | Very Strong |
| Risk | 32 | Low |
| CEO | Robert M Davis |
| Founded | Jan 1, 1891 |
| Employees | 74K |
| P/E ratio | 35.68 |
| 52-week range | $76.66 – $130.29 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-02-02 | — | 1.9825 | — | $17.09B |
| 2026-10-29 | — | 2.2009 | — | $17.48B |
| 2026-08-04 | -0.13 | -0.2733 | $16.61B | $16.53B |
| 2026-04-30 | — | -1.3698 | — | $16.06B |